Homburger advised EQT, leader of the SwissCo consortium, in the transaction. Meanwhile, Niederer Kraft Frey represented the banking syndicate consisting of Citi, Goldman Sachs, Jefferies, Morgan Stanley, and UBS. SwissCo, together with the Abu Dhabi
Tags :Estelle Piccard
Tencent Mobility Limited, a renowned internet and technology company, completed its USD 100 million strategic equity investment in Global Blue Group Holding. Tencent invested in Global Blue’s common equity at a price of USD 5.50
Meyer Burger Technology has successfully issued green senior unsecured guaranteed convertible bonds due 2029 in the aggregate amount of EUR 216.3 m. The bonds were placed in a private placement with a coupon of 3.75% per annum. The
ADC Therapeutics, a commercial-stage biotechnology company headquartered in Lausanne, announced the pricing of an underwritten offering of 12 m ADCT shares currently owned by A.T. Holdings II, an affiliate of Auven Therapeutics Holding, at a
BlackFin Capital Partners has reported the sale of its portfolio company New Access, a Geneva-based private banking technology firm, to FNZ, a global wealth management platform with registered office in London. The acquisted New Access
CSL Limited, a global biotechnology company based in Australia and Vifor Pharma, a Swiss-based global pharmaceutical company, entered into an agreement for CSL to launch an all-cash public tender offer to acquire all publicly held
ADC Therapeutics, a Lausanne-based commercial-stage oncology-focused biotechnology company, has entered into a royalty purchase agreement with HealthCare Royalty. Under the agreement, ADC Therapeutics will receive up to USD 325 million. Initial payment of USD 225 million upon
Homburger acted as Swiss counsel to Sophia Genetics on the initial listing of its shares on the Nasdaq Stock Market (ticker: SOPH). Sophia Genetics is a healthcare technology company dedicated to establishing the practice of
The team is led by partner Dieter Gericke (Corporate/M&A) and includes lead associate Daniel Häusermann (Corporate/ M&A), partners Reto Heuberger (Tax) and Benjamin Leisinger (Banking and Finance), as well as associates
Homburger advised ADCT Therapeutics on this transaction. The team was led by partner Dieter Gericke
